Aurobindo Pharma's biosimilar for breast cancer recommended for EU approval, demonstrating similarity to Herceptin.

Used for treatment of HER2-positive metastatic and early breast cancers ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the ...

多发性骨髓瘤（MM）治疗面临耐药难题，研究人员针对 MTHFD2 在 MM 中的作用展开研究。发现 MTHFD2 在 MM 中高表达且与预后不良相关，靶向它可抑制 MM，还能与硼替佐米协同抗癌。为 MM 治疗提供新思路。